Compare Becton Dickinson and Co (BDX) vs Coinbase Global, Inc. (COIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Coinbase Global, Inc. — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Coinbase Global, Inc. trades at $148.9 (market cap $39.23B). The key difference: Becton Dickinson and Co is the larger of the two by market cap, and Becton Dickinson and Co pays a 2.34% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals.
| BDX | COIN | |
|---|---|---|
Market Cap | $48.93B | $39.23B |
Sector | Health | Technology |
52-Week High | $185.39 | $387.27 |
52-Week Low | $138.62 | $141.09 |
Enterprise Value | $65.03B | $36.88B |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
COIN trades at $153.6, up 5.63% in the past 24 hours, but technical indicators signal a bearish trend with resistance near $157. The company reported Q2 2026 revenue of $1.22 billion, missing estimates, and a net loss of $359.5 million, though adjusted EBITDA remained positive for the 14th consecutive quarter. Analyst consensus is a Buy with a $207.20 price target, but recent news highlights crypto market weakness and a Zacks Strong Sell rating on August 6, 2026.
The outlook is mixed: strong cash flow and market share growth offer upside, but consecutive earnings misses and high valuation ratios pose risks. Investors face volatility from crypto market dependence and competitive pressures, requiring caution despite Wall Street's bullish average target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →
